**7. Conclusion**

Ataxia is a common symptom of MS that can dramatically impact the patient's quality of life. The underlying pathophysiology of ataxia in MS is not fully understood, but it is believed to be related to demyelination and neurodegeneration in specific areas of the brain. There are currently no specific therapies approved for the treatment of ataxia in MS; however, several promising therapeutic approaches are being investigated, including the use of disease-modifying therapies, rehabilitative interventions, and symptomatic treatments.
